rss
Br J Ophthalmol 84:710-713 doi:10.1136/bjo.84.7.710
  • Original Article
    • Clinical science

Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients

Table 6

Difference in spirometry measurements while using topical medication

Change in PF (l/min)
Mean (SD)
Change in FEV1 (litres)
Mean (SD)
Change in FVC (litres)
Mean (SD)
Change in FEV1/FVC (%)
Mean (SD)
Betaxolol (n = 34) −10.6 (67) 0.08 (0.40) 0.10 (0.56) −0.14 (9.2)
Brimonidine (n = 34) 2.4 (96) 0.01 (0.39) 0.30 (0.64) 0.79 (7.7)
Latanoprost (n = 33) 1.4 (67) 0.01 (0.16) 0.03 (0.42) 0.03 (9.8)
Timolol (n = 33) −26.2 (82) −0.08 (0.34) −0.02 (0.50) −2.45 (8.7)

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.